DP VII Associates L.P., 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 502 shares at $4.71 ($2K) on 2013-01-31, disclosed to the SEC on 2013-02-01.
Scheduled sale ($2k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 188 | $940 | 38.9% |
| 2 | $4.71 | 314 | $1K | 61.1% |
| Total | $4.82 avg | 502 | $2K | 100% |
| Filing → |
| EVOK | SELL | 2016-04-21 | $4K | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |
| ESPR | BUY | 2013-07-02 | $67K | — | Filing → |